These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 30905529

  • 1. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K, Mutembo S, Carcelen A, Matakala HK, Munachoonga P, Winter A, Wanyiri JW, Searle K, Mwansa FD, Mwiche A, Phiri C, Book C, Thuma PE, Moss WJ.
    Vaccine; 2019 Apr 17; 37(17):2387-2393. PubMed ID: 30905529
    [Abstract] [Full Text] [Related]

  • 2. Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern Province, Zambia.
    Mutembo S, Carcelen A, Mwansa FD, Searle K, Wanyiri JW, Book C, Thuma PE, Moss WJ, Hayford K.
    Am J Trop Med Hyg; 2018 Dec 17; 99(6):1639-1642. PubMed ID: 30277204
    [Abstract] [Full Text] [Related]

  • 3. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC, Mutembo S, Matakala KH, Chilumba I, Mulundu G, Monze M, Mwansa FD, Moss WJ, Hayford K.
    Am J Trop Med Hyg; 2021 May 03; 104(6):2229-2232. PubMed ID: 33939639
    [Abstract] [Full Text] [Related]

  • 4. How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia.
    Carcelen AC, Hayford K, Moss WJ, Book C, Thuma PE, Mwansa FD, Patenaude B.
    PLoS One; 2020 May 03; 15(10):e0240734. PubMed ID: 33057405
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022.
    Shanmugasundaram D, Viswanathan R, Winter AK, Agarwal A, Roychowdhury B, Muliyil D, Prasad GRV, Pushpalatha K, Gowda M, Singh P, Priyasree J, Bonu R, Jha S, Kumar Jena S, Jain S, Suri V, Hebbale V, Jain A, Mary Abraham A, Mishra B, Kumar Pati B, Biswas D, Pratkeye D, Ashok M, Singh MP, Dhodapkar R, Ray R, Gadepalli R, Ratho RK, Rani S, Shukla S, Ali A S, Lakshmi Nag V, Sabarinathan R, Saravana Kumar V, Priya R P, Dwibedi B, Sapkal G, Singh H, Singh K, Tiwari L, Jain M, Mondal N, Sreenivasan P, Mahantesh S, Verma S, Awasthi S, Malik S, Santhanam S, Datta S, Kumar A, Kant Chowdhary B, Khera D, Jain M, Kumar P, Pati S, Tripathi S, Murhekar M.
    Vaccine; 2024 Oct 24; 42(24):126077. PubMed ID: 38960788
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020.
    Murhekar MV, Gupta N, Hasan AZ, Kumar MS, Kumar VS, Prosperi C, Sapkal GN, Thangaraj JWV, Kaduskar O, Bhatt V, Deshpande GR, Thankappan UP, Bansal AK, Chauhan SL, Grover GS, Jain AK, Kulkarni RN, Sharma SK, Chaaithanya IK, Kharwal S, Mishra SK, Salvi NR, Sharma S, Sarmah NP, Sabarinathan R, Duraiswamy A, Rani DS, Kanagasabai K, Lachyan A, Gawali P, Kapoor M, Shrivastava AK, Chonker SK, Tilekar B, Tandale BV, Ahmad M, Sangal L, Winter A, Mehendale SM, Moss WJ, Hayford K.
    Lancet Glob Health; 2022 Nov 24; 10(11):e1655-e1664. PubMed ID: 36240831
    [Abstract] [Full Text] [Related]

  • 12. Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space.
    Carcelen AC, Winter AK, Moss WJ, Chilumba I, Mutale I, Chongwe G, Monze M, Mulundu G, Nkamba H, Mwansa FD, Mulenga L, Rhoda DA, Hayford K, Mutembo S.
    Sci Rep; 2022 Jun 17; 12(1):10217. PubMed ID: 35715547
    [Abstract] [Full Text] [Related]

  • 13. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign.
    Honarvar B, Moghadami M, Moattari A, Emami A, Odoomi N, Bagheri Lankarani K.
    PLoS One; 2013 Jun 17; 8(1):e55043. PubMed ID: 23383049
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Australian rubella serosurvey 2012-2013: On track for elimination?
    Edirisuriya C, Beard FH, Hendry AJ, Dey A, Gidding HF, Hueston L, Dwyer DE, Wood JG, Macartney KK, McIntyre PB.
    Vaccine; 2018 May 11; 36(20):2794-2798. PubMed ID: 29661586
    [Abstract] [Full Text] [Related]

  • 18. Rubella and measles seroprevalence among women of childbearing age, Argentina, 2002.
    Dayan GH, Panero MS, Urquiza A, Molina M, Prieto S, Del Carmen Perego M, Scagliotti G, Galimberti D, Carroli G, Wolff C, Bi D, Bellini W, Icenogle J, Reef S.
    Epidemiol Infect; 2005 Oct 11; 133(5):861-9. PubMed ID: 16181506
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey.
    Wanlapakorn N, Wasitthankasem R, Vichaiwattana P, Auphimai C, Yoocharoen P, Vongpunsawad S, Poovorawan Y.
    PLoS One; 2019 Oct 11; 14(11):e0225606. PubMed ID: 31770412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.